141 related articles for article (PubMed ID: 10524451)
1. Serum soluble CD44 in pediatric patients with acute leukemia.
Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M
J Pediatr Hematol Oncol; 1999; 21(5):384-8. PubMed ID: 10524451
[TBL] [Abstract][Full Text] [Related]
2. Study of soluble CD44 and its expression by mononuclear cells in children with acute lymphoblastic leukemia: its relation to prognostic factors.
Ahmed MI; Hassab HM
Egypt J Immunol; 2008; 15(2):101-11. PubMed ID: 20306693
[TBL] [Abstract][Full Text] [Related]
3. Serum levels and differential expression of CD44 in childhood leukemia and malignant lymphoma: correlation with prognostic criteria and survival.
Taçyildiz N; Cavdar AO; Yavuz G; Gözdaşoglu S; Unal E; Ertem U; Duru F; Ikinciogullari A; Babacan E; Kuzu I; Cin S
Pediatr Int; 2001 Aug; 43(4):354-60. PubMed ID: 11472578
[TBL] [Abstract][Full Text] [Related]
4. Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes.
Nasu H; Hibi N; Ohyashiki JH; Hara A; Kubono K; Tsukada Y; Ando K; Iwama H; Hayashi S; Yahata N; Toyama K; Ohyashiki K
Int J Oncol; 1998 Sep; 13(3):525-30. PubMed ID: 9683788
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia.
Amirghofran Z; Asiaee E; Kamazani FM
Asia Pac J Clin Oncol; 2016 Sep; 12(3):e375-82. PubMed ID: 25227983
[TBL] [Abstract][Full Text] [Related]
6. High levels of the shed form of L-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium.
Spertini O; Callegari P; Cordey AS; Hauert J; Joggi J; von Fliedner V; Schapira M
Blood; 1994 Aug; 84(4):1249-56. PubMed ID: 7519478
[TBL] [Abstract][Full Text] [Related]
7. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
Leahey AM; Bunin NJ; Belasco JB; Meek R; Scher C; Lange BJ
Med Pediatr Oncol; 2000 May; 34(5):313-8. PubMed ID: 10797352
[TBL] [Abstract][Full Text] [Related]
8. Potential use of serum CD44 as an indicator of tumour progression in acute leukemia.
Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
Hematol Oncol; 1999 Dec; 17(4):161-8. PubMed ID: 10725871
[TBL] [Abstract][Full Text] [Related]
9. A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
van Eys J; Berry D; Crist W; Doering E; Fernbach D; Pullen J; Shuster J; Wharam M
Cancer; 1989 Jan; 63(1):23-9. PubMed ID: 2910421
[TBL] [Abstract][Full Text] [Related]
10. [The effect of polychemotherapy on hemopoiesis in acute lymphoblastic leukemia in children].
Vladimirskaia EB; Zamarraeva NV; Lebedev VV; Kryzhanovskiĭ OI; Rumiantsev AG; Sallakh S; Tabet S; Mazo IB
Gematol Transfuziol; 1993 May; 38(5):6-10. PubMed ID: 8034176
[TBL] [Abstract][Full Text] [Related]
11. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
[TBL] [Abstract][Full Text] [Related]
12. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
[TBL] [Abstract][Full Text] [Related]
13. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S;
Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells.
Stahnke K; Eckhoff S; Mohr A; Meyer LH; Debatin KM
Leukemia; 2003 Nov; 17(11):2130-9. PubMed ID: 14523471
[TBL] [Abstract][Full Text] [Related]
15. High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma.
Niitsu N; Iijima K
Leuk Res; 2002 Mar; 26(3):241-8. PubMed ID: 11792412
[TBL] [Abstract][Full Text] [Related]
16. Therapy of acute leukemia with drug combinations which include asparaginase.
Leventhal BG; Henderson ES
Cancer; 1971 Oct; 28(4):825-9. PubMed ID: 5286445
[No Abstract] [Full Text] [Related]
17. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis.
Lackner C; Moser R; Bauernhofer T; Wilders-Truschnig M; Samonigg H; Berghold A; Zatloukal K
Breast Cancer Res Treat; 1998 Jan; 47(1):29-40. PubMed ID: 9493973
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy of relapsed AML and ALL].
Nishikawa K
Rinsho Ketsueki; 1996 Aug; 37(8):647-50. PubMed ID: 8827871
[No Abstract] [Full Text] [Related]
19. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM
Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139
[TBL] [Abstract][Full Text] [Related]
20. Acute lymphoblastic leukemia in Ehlers-Danlos syndrome.
Asano T; Yamamoto M
Int J Hematol; 1996 Oct; 64(3-4):283-5. PubMed ID: 8923793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]